Loading insider details...
Beta
Latest Form 4 (Oct 6, 2026): Sale of 1,864 NTLA shares, $23.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Intellia Therapeutics, Inc. (NTLA) | Sale | 1,864 | $23.2K |
| Jul 6, 2026 | Intellia Therapeutics, Inc. (NTLA) | Sale | 2,641 | $44.3K |
| Mar 3, 2026 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 17,250 | n/a |
| Jan 7, 2026 | Intellia Therapeutics, Inc. (NTLA) | Sale | 2,989 | $27.5K |
| Oct 3, 2025 | Intellia Therapeutics, Inc. (NTLA) | Sale | 1,871 | $32.5K |
| Jul 3, 2025 | Intellia Therapeutics, Inc. (NTLA) | Sale | 2,503 | $24.9K |
| Mar 4, 2025 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 14,000 | n/a |
| Jan 7, 2025 | Intellia Therapeutics, Inc. (NTLA) | Sale | 1,372 | $16.7K |
| Oct 4, 2024 | Intellia Therapeutics, Inc. (NTLA) | Sale | 2,012 | $38.2K |
| Jul 3, 2024 | Intellia Therapeutics, Inc. (NTLA) | Grant/Award | 17,801 | n/a |